알레르기 주사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Allergy Shots Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,964,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,171,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,844,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 알레르기 주사 세계 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학을 철저히 평가하고 시장 구조에 대한 심층적인 인사이트를 제공합니다.

주요 인사이트

• 알레르기 주사 시장 규모(2024년) : 28억 7,590만 달러
• 예상 시장 규모(2033년) : 64억 7,270만 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 9.4%

알레르기 주사 시장 - 조사 범위

알레르기 면역요법이라고도 알려진 알레르기 주사는 특정 알레르겐에 대한 면역 체계를 점진적으로 감작시켜 알레르기 반응을 치료하는 데 사용됩니다. 이 주사는 수개월에서 수년까지 투여되며 꽃가루, 진드기, 곰팡이, 애완동물의 비듬과 같은 물질에 대한 알레르기를 관리하는 데 사용됩니다. 이 시장은 병원, 클리닉, 알레르기 전문 센터 및 재택 치료 현장을 위해 다양한 치료 요법과 제형을 제공하고 있습니다.

시장 성장의 원동력은 알레르기 질환의 유병률 증가, 의료비 지출 증가, 면역요법 기술의 발전으로 인한 치료 효과와 환자 결과 개선입니다.

시장 성장 촉진요인:

세계 알레르기 주사 시장은 알레르기 질환의 유병률 증가와 효과적인 치료 옵션으로서 알레르겐 면역요법에 대한 인식이 높아지는 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 알레르기성 비염, 천식 및 기타 알레르기 질환의 유병률 증가가 시장 확대에 기여하고 있습니다. 또한, 보다 효과적이고 개별화된 알레르겐 추출물의 개발 및 투여 기술 향상과 같은 기술적 진보도 시장 성장의 원동력이 되고 있습니다. 또한, 장기적인 해결책을 찾는 환자들 사이에서 알레르기 주사의 채택이 증가하고 있으며, 증상 치료제에 대한 의존도가 감소하고 있는 것도 시장 수요를 더욱 촉진하고 있습니다.

시장 억제요인:

알레르기 주사 시장은 유망한 성장 전망에도 불구하고 치료 기간, 비용, 환자 순응도 등의 문제에 직면해 있습니다. 일부 환자들은 긴 치료 기간과 잦은 의료기관 방문으로 인해 알레르기 주사를 기피하는 경향이 있습니다. 높은 치료 비용과 알레르겐 면역요법에 대한 제한된 보험 적용은 특히 의료 예산이 제한된 신흥국에서 시장 침투에 영향을 미칠 수 있습니다. 이러한 장벽을 극복하기 위해서는 환자 교육 강화, 저렴한 치료 옵션에 대한 접근성 개선, 알레르겐 면역요법에 대한 보험 적용 확대가 필요합니다.

시장 기회:

알레르기 주사 시장은 기술 혁신, 인구 동향, 의료 서비스 제공 모델의 진화로 인해 큰 성장 기회를 맞이하고 있습니다. 알레르기 검사 및 진단 도구의 발전으로 환자 식별 및 치료 맞춤화가 개선되고 있습니다. 또한, 모바일 건강 애플리케이션 및 원격의료 플랫폼과 같은 디지털 건강 기술의 통합은 환자의 알레르기 치료에 대한 접근성과 치료 순응도를 향상시키고 있습니다. 식품 알레르기 및 만성 부비동염에 대한 적용 가능성 등 알레르겐 면역 치료의 적응증 확대는 시장 범위를 넓히고 기술 혁신을 촉진하고 있습니다.

본 보고서에서 다루는 주요 질문들

• 알레르기 주사 시장의 세계 성장을 촉진하는 주요 요인은 무엇인가?
• 알레르기 면역 치료 기술의 발전은 시장 역학에 어떤 영향을 미쳤습니까?
• 알레르기 주사 시장이 직면한 주요 과제는 무엇이며 어떻게 대처할 수 있는가?
• 알레르기 주사 시장의 주요 기업은 어디에 있으며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 알레르기 주사 시장의 새로운 트렌드와 향후 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 주요 성공요인

• 제품 채용/사용 상황 분석
• 제품 USP/특징
• 파이프라인 평가
• 최근의 제품 승인과 발매
• PESTLE 분석
• Porters 분석
• 규제 시나리오
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 역학

제6장 COVID-19 위기 - 영향 평가

• COVID-19와 영향 분석
  • 제품별
  • 면역요법별
  • 적응증
  • 알레르겐별
  • 유통 채널별
  • 지역별
• 2024년 시장 시나리오

제7장 세계 시장 수량(단위) 분석

• 과거 수량(단위) 분석, 2019-2023년
• 현재 및 향후 수량(단위) 예측, 2024-2033년
  • 전년비 성장 동향 분석

제8장 세계 시장 - 가격 분석

• 지역별 가격 분석 : 제품별
• 가격 내역
  • 제조업체 레벨 가격 설정
  • 유통업체 레벨 가격 설정
• 세계 평균 가격 분석 벤치마크
• 가격 설정 가정

제9장 세계 시장 수요(금액 또는 규모, 백만 달러) 분석

• 과거 시장 금액(백만 달러) 분석, 2019-2023년
• 현재 및 향후 시장 금액(백만 달러) 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대액 기회 분석

제10장 세계 시장 분석, 제품별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러)와 수량(단위) 분석, 제품별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러)와 수량(단위) 분석과 예측, 제품별, 2024-2033년
  • SLIT 태블릿
  • 경구
  • 주사
  • 기타
• 시장 매력 분석 : 제품별

제11장 세계 시장 분석, 면역요법별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석, 면역요법별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측, 면역요법별, 2024-2033년
  • 설하 면역요법(SLIT)
  • 피하 면역요법(SCIT)
  • 기타
• 시장 매력 분석 : 면역요법별

제12장 세계 시장 분석, 적응증별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석, 적응증별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측, 적응증별, 2024-2033년
  • 알레르기 비염
  • 알레르기성 천식
  • 식품 알레르기
  • 아토피 피부염
  • 기타
• 시장 매력 분석 : 적응증별

제13장 세계 시장 분석, 알레르겐별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석, 알레르겐별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측, 알레르겐별, 2024-2033년
  • 화분
  • 집먼지진드기(HDM)
  • 형
  • 동물 늙어
  • 봉독
  • 바퀴벌레/곤충
  • 기타
• 시장 매력 분석 : 알레르겐별

제14장 세계 시장 분석, 유통 채널별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석, 유통 채널별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측, 유통 채널별, 2024-2033년
  • 기관투자가용 판매
  • 소매 판매
• 시장 매력 분석 : 유통 채널별

제15장 세계 시장 분석 : 지역별

• 소개
• 과거 시장 규모(백만 달러) 분석, 지역별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측, 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 시장 매력 분석 : 지역별

제16장 북미 시장 분석

제17장 라틴아메리카 시장 분석

제18장 유럽 시장 분석

제19장 남아시아 시장 분석

제20장 동아시아 시장 분석

제21장 오세아니아 시장 분석

제22장 중동 및 아프리카 시장 분석

제23장 시장 구조 분석

• 시장 분석 : 기업 계층별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제24장 경쟁 분석

• 경쟁 대시보드
• 브랜딩과 프로모션 전략
• 주요 개발 분석
• 경쟁 상세 정보
  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies

제25장 사용되는 가정과 두문자어

제26장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for allergy shots. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Allergy Shots Market Size (2024E): USD 2,875.9 million
• Projected Market Value (2033F): USD 6,472.7 million
• Global Market Growth Rate (CAGR 2024 to 2033): 9.4%

Allergy Shots Market - Report Scope:

Allergy shots, also known as allergen immunotherapy, are used to treat allergic reactions by gradually desensitizing the immune system to specific allergens. These shots are administered over a period of months or years and are used to manage allergies to substances such as pollen, dust mites, mold, and pet dander. The market caters to hospitals, clinics, specialized allergy centers, and homecare settings, offering various treatment regimens and formulations.

Market growth is driven by an increasing prevalence of allergic disorders, rising healthcare expenditures, and advancements in immunotherapy techniques, enhancing treatment efficacy and patient outcomes.

Market Growth Drivers:

The global allergy shots market is propelled by several key factors, including the growing incidence of allergic diseases and an increasing awareness of allergen immunotherapy as an effective treatment option. The rising prevalence of allergic rhinitis, asthma, and other allergic conditions is contributing to market expansion. Technological advancements, such as the development of more effective and personalized allergen extracts and improvements in administration techniques, are also driving market growth. Additionally, the growing adoption of allergy shots among patients seeking long-term solutions and reduced dependency on symptomatic medications further fuels market demand.

Market Restraints:

Despite promising growth prospects, the allergy shots market faces challenges related to treatment duration, cost, and patient compliance. The lengthy treatment duration and the need for frequent visits to healthcare providers can deter some patients from pursuing allergy shots. High treatment costs and limited insurance coverage for allergen immunotherapy may also impact market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these barriers requires enhanced patient education, improved access to affordable treatment options, and greater insurance coverage for allergen immunotherapy.

Market Opportunities:

The allergy shots market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. Advances in allergy testing and diagnostic tools are improving patient identification and treatment customization. Additionally, the integration of digital health technologies, such as mobile health applications and telemedicine platforms, enhances patient access to allergy care and treatment adherence. Expanding indications for allergen immunotherapy, including potential applications for food allergies and chronic sinusitis, broadens the market scope and stimulates innovation.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the allergy shots market globally?
• How are advancements in allergen immunotherapy techniques influencing market dynamics?
• What are the key challenges faced by the allergy shots market, and how can they be addressed?
• Who are the leading players in the allergy shots market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global allergy shots market?

Competitive Intelligence and Business Strategy:

Leading players in the global allergy shots market, including companies such as Allergy Therapeutics, Stallergenes Greer, and HAL Allergy, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced allergen extracts and delivery systems, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical research institutions, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient education is essential to drive market growth and enhance patient outcomes in the evolving allergy shots landscape.

Key Companies Profiled:

• Allergy Therapeutics
• Stallergenes Greer
• HAL Allergy
• Merck & Co., Inc.
• Novartis AG
• Antigen Laboratories
• ALK-Abello A/S
• DBV Technologies
• Schering-Plough Corporation
• Mylan N.V.

Key Segments Covered in Allergy Shots Industry Research

Product:

• SLIT Tablets
• Oral
• Injections

Immunotherapy:

• Sublingual Immunotherapy (SLIT)
• Subcutaneous Immunotherapy (SCIT)
• Specific Immunotherapy

Indication:

• Allergic Rhinitis
• Allergic Asthma
• Food Allergy
• Atopic Dermatitis

Allergen:

• Pollens
• House Dust Mites (HDM)
• Mold
• Animal Dander
• Bee Venom
• Cockroaches/Insects

Distribution Channel:

• Institutional Sales
• Retail Sales

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Pipeline Assessment
• 4.4. Recent Product Approval and Launches
• 4.5. PESTLE Analysis
• 4.6. Porter's Analysis
• 4.7. Regulatory Scenario
• 4.8. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Allergy Diagnostics Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Growth of the Top Companies
  • 5.2.2. Rising Prevalence of Various Types of Allergies
  • 5.2.3. Cost of Products
  • 5.2.4. Product and Stock Availability
  • 5.2.5. Mergers and Acquisitions
  • 5.2.6. Changing Lifestyle
  • 5.2.7. Strong Product Pipeline
  • 5.2.8. Growing Corporate Agreements
• 5.3. Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Immunotherapy
  • 6.1.3. BY Indication
  • 6.1.4. By Allergen
  • 6.1.5. By Distribution Channel
  • 6.1.6. By Region
• 6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Volume (in Units) Analysis, 2019-2023
• 7.2. Current and Future Volume (in Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
  • 10.3.1. SLIT Tablets
    • 10.3.1.1. Odactra
    • 10.3.1.2. Grastek
    • 10.3.1.3. Ragwitek
    • 10.3.1.4. Oralair
    • 10.3.1.5. Actair
    • 10.3.1.6. Others
  • 10.3.2. Oral
    • 10.3.2.1. Palforzia
    • 10.3.2.2. Others
  • 10.3.3. Injections
  • 10.3.4. Others
• 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Immunotherapy

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By Immunotherapy, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Immunotherapy, 2024-2033
  • 11.3.1. Sublingual Immunotherapy (SLIT)
  • 11.3.2. Subcutaneous Immunotherapy (SCIT)
    • 11.3.2.1. Specific Immunotherapy
  • 11.3.3. Others
• 11.4. Market Attractiveness Analysis By Immunotherapy

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2033
  • 12.3.1. Allergic Rhinitis
  • 12.3.2. Allergic Asthma
  • 12.3.3. Food Allergy
  • 12.3.4. Atopic Dermatitis
  • 12.3.5. Others
• 12.4. Market Attractiveness Analysis By Indication

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Allergen

• 13.1. Introduction / Key Findings
• 13.2. Historical Market Size (US$ Mn) Analysis By Allergen, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Allergen, 2024-2033
  • 13.3.1. Pollens
    • 13.3.1.1. Grass Pollens
    • 13.3.1.2. Weed Pollens
    • 13.3.1.3. Tree Pollens
  • 13.3.2. House Dust Mites (HDM)
  • 13.3.3. Mould
  • 13.3.4. Animal Dander
  • 13.3.5. Bee Venom
  • 13.3.6. Cockroaches/Insects
  • 13.3.7. Others
• 13.4. Market Attractiveness Analysis By Allergen

14. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Distribution Channel

• 14.1. Introduction / Key Findings
• 14.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2033
  • 14.3.1. Institutional Sales
    • 14.3.1.1. Government Hospitals
    • 14.3.1.2. Semi-Government Hospitals
    • 14.3.1.3. Private Hospitals
  • 14.3.2. Retail Sales
    • 14.3.2.1. Retail Pharmacy
    • 14.3.2.2. Drug Stores
    • 14.3.2.3. Online Pharmacy
• 14.4. Market Attractiveness Analysis By Distribution Channel

15. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
  • 15.3.1. North America
  • 15.3.2. Latin America
  • 15.3.3. Europe
  • 15.3.4. South Asia
  • 15.3.5. East Asia
  • 15.3.6. Oceania
  • 15.3.7. Middle East and Africa (MEA)
• 15.4. Market Attractiveness Analysis By Region

16. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. U.S.
    • 16.3.1.2. Canada
  • 16.3.2. By Product
  • 16.3.3. By Immunotherapy
  • 16.3.4. By Indication
  • 16.3.5. By Allergen
  • 16.3.6. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Immunotherapy
  • 16.4.4. By Indication
  • 16.4.5. By Allergen
  • 16.4.6. By Distribution Channel
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. U.S. Market Analysis
    • 16.5.1.1. Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Product
      • 16.5.1.2.2. By Immunotherapy
      • 16.5.1.2.3. By Indication
      • 16.5.1.2.4. By Allergen
      • 16.5.1.2.5. By Distribution Channel
  • 16.5.2. Canada Market Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Product
      • 16.5.2.2.2. By Immunotherapy
      • 16.5.2.2.3. By Indication
      • 16.5.2.2.4. By Allergen
      • 16.5.2.2.5. By Distribution Channel
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. Brazil
    • 17.3.1.2. Mexico
    • 17.3.1.3. Argentina
    • 17.3.1.4. Rest of Latin America
  • 17.3.2. By Product
  • 17.3.3. By Immunotherapy
  • 17.3.4. By Indication
  • 17.3.5. By Allergen
  • 17.3.6. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Immunotherapy
  • 17.4.4. By Indication
  • 17.4.5. By Allergen
  • 17.4.6. By Distribution Channel
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. Brazil Market Analysis
    • 17.5.1.1. Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Product
      • 17.5.1.2.2. By Immunotherapy
      • 17.5.1.2.3. By Indication
      • 17.5.1.2.4. By Allergen
      • 17.5.1.2.5. By Distribution Channel
  • 17.5.2. Mexico Market Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Product
      • 17.5.2.2.2. By Immunotherapy
      • 17.5.2.2.3. By Indication
      • 17.5.2.2.4. By Allergen
      • 17.5.2.2.5. By Distribution Channel
  • 17.5.3. Argentina Market Analysis
    • 17.5.3.1. Introduction
    • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.3.2.1. By Product
      • 17.5.3.2.2. By Immunotherapy
      • 17.5.3.2.3. By Indication
      • 17.5.3.2.4. By Allergen
      • 17.5.3.2.5. By Distribution Channel
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Germany
    • 18.3.1.2. France
    • 18.3.1.3. Italy
    • 18.3.1.4. U.K.
    • 18.3.1.5. Spain
    • 18.3.1.6. Russia
    • 18.3.1.7. BENELUX
    • 18.3.1.8. Rest of Europe
  • 18.3.2. By Product
  • 18.3.3. By Immunotherapy
  • 18.3.4. By Indication
  • 18.3.5. By Allergen
  • 18.3.6. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Immunotherapy
  • 18.4.4. By Indication
  • 18.4.5. By Allergen
  • 18.4.6. By Distribution Channel
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. Germany Market Analysis
    • 18.5.1.1. Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Product
      • 18.5.1.2.2. By Immunotherapy
      • 18.5.1.2.3. By Indication
      • 18.5.1.2.4. By Allergen
      • 18.5.1.2.5. By Distribution Channel
  • 18.5.2. France Market Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Product
      • 18.5.2.2.2. By Immunotherapy
      • 18.5.2.2.3. By Indication
      • 18.5.2.2.4. By Allergen
      • 18.5.2.2.5. By Distribution Channel
  • 18.5.3. Italy Market Analysis
    • 18.5.3.1. Introduction
    • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.3.2.1. By Product
      • 18.5.3.2.2. By Immunotherapy
      • 18.5.3.2.3. By Indication
      • 18.5.3.2.4. By Allergen
      • 18.5.3.2.5. By Distribution Channel
  • 18.5.4. U.K. Market Analysis
    • 18.5.4.1. Introduction
    • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.4.2.1. By Product
      • 18.5.4.2.2. By Immunotherapy
      • 18.5.4.2.3. By Indication
      • 18.5.4.2.4. By Allergen
      • 18.5.4.2.5. By Distribution Channel
  • 18.5.5. Spain Market Analysis
    • 18.5.5.1. Introduction
    • 18.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.5.2.1. By Product
      • 18.5.5.2.2. By Immunotherapy
      • 18.5.5.2.3. By Indication
      • 18.5.5.2.4. By Allergen
      • 18.5.5.2.5. By Distribution Channel
  • 18.5.6. Russia Market Analysis
    • 18.5.6.1. Introduction
    • 18.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.6.2.1. By Product
      • 18.5.6.2.2. By Immunotherapy
      • 18.5.6.2.3. By Indication
      • 18.5.6.2.4. By Allergen
      • 18.5.6.2.5. By Distribution Channel
  • 18.5.7. BENELUX Market Analysis
    • 18.5.7.1. Introduction
    • 18.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.7.2.1. By Product
      • 18.5.7.2.2. By Immunotherapy
      • 18.5.7.2.3. By Indication
      • 18.5.7.2.4. By Allergen
      • 18.5.7.2.5. By Distribution Channel
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. India
    • 19.3.1.2. Thailand
    • 19.3.1.3. Indonesia
    • 19.3.1.4. Malaysia
    • 19.3.1.5. Rest of South Asia
  • 19.3.2. By Product
  • 19.3.3. By Immunotherapy
  • 19.3.4. By Indication
  • 19.3.5. By Allergen
  • 19.3.6. By Distribution Channel
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Immunotherapy
  • 19.4.4. By Indication
  • 19.4.5. By Allergen
  • 19.4.6. By Distribution Channel
• 19.5. Country Level Analysis & Forecast
  • 19.5.1. India Market Analysis
    • 19.5.1.1. Introduction
    • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.1.2.1. By Product
      • 19.5.1.2.2. By Immunotherapy
      • 19.5.1.2.3. By Indication
      • 19.5.1.2.4. By Allergen
      • 19.5.1.2.5. By Distribution Channel
  • 19.5.2. Thailand Market Analysis
    • 19.5.2.1. Introduction
    • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.2.2.1. By Product
      • 19.5.2.2.2. By Immunotherapy
      • 19.5.2.2.3. By Indication
      • 19.5.2.2.4. By Distribution Channel
  • 19.5.3. Indonesia Market Analysis
    • 19.5.3.1. Introduction
    • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.3.2.1. By Product
      • 19.5.3.2.2. By Immunotherapy
      • 19.5.3.2.3. By Indication
      • 19.5.3.2.4. By Allergen
      • 19.5.3.2.5. By Distribution Channel
  • 19.5.4. Malaysia Market Analysis
    • 19.5.4.1. Introduction
    • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.4.2.1. By Product
      • 19.5.4.2.2. By Immunotherapy
      • 19.5.4.2.3. By Indication
      • 19.5.4.2.4. By Allergen
      • 19.5.4.2.5. By Distribution Channel
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis

20. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. China
    • 20.3.1.2. Japan
    • 20.3.1.3. South Korea
  • 20.3.2. By Product
  • 20.3.3. By Immunotherapy
  • 20.3.4. By Indication
  • 20.3.5. By Allergen
  • 20.3.6. By Distribution Channel
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Immunotherapy
  • 20.4.4. By Indication
  • 20.4.5. By Allergen
  • 20.4.6. By Distribution Channel
• 20.5. Country Level Analysis & Forecast
  • 20.5.1. China Market Analysis
    • 20.5.1.1. Introduction
    • 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.1.2.1. By Product
      • 20.5.1.2.2. By Immunotherapy
      • 20.5.1.2.3. By Indication
      • 20.5.1.2.4. By Allergen
      • 20.5.1.2.5. By Distribution Channel
  • 20.5.2. Japan Market Analysis
    • 20.5.2.1. Introduction
    • 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.2.2.1. By Product
      • 20.5.2.2.2. By Immunotherapy
      • 20.5.2.2.3. By Indication
      • 20.5.2.2.4. By Allergen
      • 20.5.2.2.5. By Distribution Channel
  • 20.5.3. South Korea Market Analysis
    • 20.5.3.1. Introduction
    • 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.3.2.1. By Product
      • 20.5.3.2.2. By Immunotherapy
      • 20.5.3.2.3. By Indication
      • 20.5.3.2.4. By Allergen
      • 20.5.3.2.5. By Distribution Channel
• 20.6. Market Trends
• 20.7. Key Market Participants - Intensity Mapping
• 20.8. Drivers and Restraints - Impact Analysis

21. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 21.1. Introduction
• 21.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 21.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 21.3.1. By Country
    • 21.3.1.1. Australia
    • 21.3.1.2. New Zealand
  • 21.3.2. By Product
  • 21.3.3. By Immunotherapy
  • 21.3.4. By Indication
  • 21.3.5. By Allergen
  • 21.3.6. By Distribution Channel
• 21.4. Market Attractiveness Analysis
  • 21.4.1. By Country
  • 21.4.2. By Product
  • 21.4.3. By Immunotherapy
  • 21.4.4. By Indication
  • 21.4.5. By Allergen
  • 21.4.6. By Distribution Channel
• 21.5. Country Level Analysis & Forecast
  • 21.5.1. Australia Market Analysis
    • 21.5.1.1. Introduction
    • 21.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 21.5.1.2.1. By Product
      • 21.5.1.2.2. By Immunotherapy
      • 21.5.1.2.3. By Indication
      • 21.5.1.2.4. By Allergen
      • 21.5.1.2.5. By Distribution Channel
  • 21.5.2. New Zealand Market Analysis
    • 21.5.2.1. Introduction
    • 21.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 21.5.2.2.1. By Product
      • 21.5.2.2.2. By Immunotherapy
      • 21.5.2.2.3. By Indication
      • 21.5.2.2.4. By Allergen
      • 21.5.2.2.5. By Distribution Channel
• 21.6. Market Trends
• 21.7. Key Market Participants - Intensity Mapping
• 21.8. Drivers and Restraints - Impact Analysis

22. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

• 22.1. Introduction
• 22.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 22.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 22.3.1. By Country
    • 22.3.1.1. GCC Countries
    • 22.3.1.2. Turkiye
    • 22.3.1.3. Northern Africa
    • 22.3.1.4. South Africa
    • 22.3.1.5. Rest of Middle East and Africa
  • 22.3.2. By Product
  • 22.3.3. By Immunotherapy
  • 22.3.4. By Indication
  • 22.3.5. By Allergen
  • 22.3.6. By Distribution Channel
• 22.4. Market Attractiveness Analysis
  • 22.4.1. By Country
  • 22.4.2. By Product
  • 22.4.3. By Immunotherapy
  • 22.4.4. By Indication
  • 22.4.5. By Allergen
  • 22.4.6. By Distribution Channel
• 22.5. Country Level Analysis & Forecast
  • 22.5.1. GCC Countries Market Analysis
    • 22.5.1.1. Introduction
    • 22.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 22.5.1.2.1. By Product
      • 22.5.1.2.2. By Immunotherapy
      • 22.5.1.2.3. By Indication
      • 22.5.1.2.4. By Allergen
      • 22.5.1.2.5. By Distribution Channel
  • 22.5.2. Turkiye Market Analysis
    • 22.5.2.1. Introduction
    • 22.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 22.5.2.2.1. By Product
      • 22.5.2.2.2. By Immunotherapy
      • 22.5.2.2.3. By Indication
      • 22.5.2.2.4. By Allergen
      • 22.5.2.2.5. By Distribution Channel
  • 22.5.3. Northern Africa Market Analysis
    • 22.5.3.1. Introduction
    • 22.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 22.5.3.2.1. By Product
      • 22.5.3.2.2. By Immunotherapy
      • 22.5.3.2.3. By Indication
      • 22.5.3.2.4. By Allergen
      • 22.5.3.2.5. By Distribution Channel
  • 22.5.4. South Africa Market Analysis
    • 22.5.4.1. Introduction
    • 22.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 22.5.4.2.1. By Product
      • 22.5.4.2.2. By Immunotherapy
      • 22.5.4.2.3. By Indication
      • 22.5.4.2.4. By Allergen
      • 22.5.4.2.5. By Distribution Channel
• 22.6. Market Trends
• 22.7. Key Market Participants - Intensity Mapping
• 22.8. Drivers and Restraints - Impact Analysis

23. Market Structure Analysis

• 23.1. Market Analysis by Tier of Companies
• 23.2. Market Share Analysis of Top Players
• 23.3. Market Presence Analysis

24. Competition Analysis

• 24.1. Competition Dashboard
• 24.2. Branding and Promotional Strategies
• 24.3. Key Development Analysis
• 24.4. Competition Deep Dive
  • 24.4.1. ALK Abello
    • 24.4.1.1. Overview
    • 24.4.1.2. Product Portfolio
    • 24.4.1.3. Key Financials
    • 24.4.1.4. SWOT Analysis
    • 24.4.1.5. Sales Footprint
    • 24.4.1.6. Strategy Overview
  • 24.4.2. Stallergenes Greer
    • 24.4.2.1. Overview
    • 24.4.2.2. Product Portfolio
    • 24.4.2.3. Key Financials
    • 24.4.2.4. SWOT Analysis
    • 24.4.2.5. Sales Footprint
    • 24.4.2.6. Strategy Overview
  • 24.4.3. Allergy Therapeutics
    • 24.4.3.1. Overview
    • 24.4.3.2. Product Portfolio
    • 24.4.3.3. Key Financials
    • 24.4.3.4. SWOT Analysis
    • 24.4.3.5. Sales Footprint
    • 24.4.3.6. Strategy Overview
  • 24.4.4. Aimmune Therapeutics
    • 24.4.4.1. Overview
    • 24.4.4.2. Product Portfolio
    • 24.4.4.3. Key Financials
    • 24.4.4.4. SWOT Analysis
    • 24.4.4.5. Sales Footprint
    • 24.4.4.6. Strategy Overview
  • 24.4.5. Anergis
    • 24.4.5.1. Overview
    • 24.4.5.2. Product Portfolio
    • 24.4.5.3. Key Financials
    • 24.4.5.4. SWOT Analysis
    • 24.4.5.5. Sales Footprint
    • 24.4.5.6. Strategy Overview
  • 24.4.6. Arrayit Corporation
    • 24.4.6.1. Overview
    • 24.4.6.2. Product Portfolio
    • 24.4.6.3. Key Financials
    • 24.4.6.4. SWOT Analysis
    • 24.4.6.5. Sales Footprint
    • 24.4.6.6. Strategy Overview
  • 24.4.7. Biomay AG
    • 24.4.7.1. Overview
    • 24.4.7.2. Product Portfolio
    • 24.4.7.3. Key Financials
    • 24.4.7.4. SWOT Analysis
    • 24.4.7.5. Sales Footprint
    • 24.4.7.6. Strategy Overview
  • 24.4.8. HAL Allergy Group
    • 24.4.8.1. Overview
    • 24.4.8.2. Product Portfolio
    • 24.4.8.3. Key Financials
    • 24.4.8.4. SWOT Analysis
    • 24.4.8.5. Sales Footprint
    • 24.4.8.6. Strategy Overview
  • 24.4.9. DBV Technologies
    • 24.4.9.1. Overview
    • 24.4.9.2. Product Portfolio
    • 24.4.9.3. Key Financials
    • 24.4.9.4. SWOT Analysis
    • 24.4.9.5. Sales Footprint
    • 24.4.9.6. Strategy Overview

25. Assumptions and Acronyms Used

26. Research Methodology

관련자료